Dev Labtech Venture Ltd

BSE: 543848

23

total announcements

543848.BO · 15 min delayed

BSEResultResults6 Nov 2026

Dev Labtech Venture Ltd

Unaudited Standalone and Consolidated Financial Results for the Half Year ended 30th September, 2026 along with Limited Review Report of Statutory Auditor.

Dev Labtech Venture Ltd has announced its unaudited standalone and consolidated financial results for the half year ended 30th September, 2026. The results include revenue from operations, other income, total income, expenses, profit before tax, and profit after tax. The company has also enclosed a limited review report issued by the statutory auditor.

Read more →📎 1 attachment
BSEBoard MeetingResults6 Nov 2026

Dev Labtech Venture Ltd

Outcome of Board Meeting

Dev Labtech Venture Ltd has announced the outcome of its board meeting held on 6th November, 2026. The board considered and approved the unaudited standalone and consolidated financial results for the half year ended 30th September, 2026. The company's management has reviewed the financial statements and has been approved by the board of directors.

Read more →📎 1 attachment
BSEBoard MeetingResults30 Oct 2026

Dev Labtech Venture Ltd

Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve To consider and approve the Unaudited Standalone and Consolidated Financial Results for the Half Year ended 30th September, 2026 along with the Statement of Assets and Liabilities and Cash Flow Statement for the Half Year ended 30th September, 2026.

Dev Labtech Venture Ltd has scheduled a board meeting on 6th November 2026 to consider and approve the unaudited standalone and consolidated financial results for the half year ended 30th September 2026.

Read more →📎 1 attachment
BSEAGM/EGMM&A12 Oct 2026

Dev Labtech Venture Ltd

Notice of EGM of the Company

Dev Labtech Venture Ltd has announced a notice of Extra Ordinary General Meeting (EGM) to be held on November 5, 2026, to consider increasing the authorized share capital and issuing convertible warrants on a preferential issue basis.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Oct 2026

Dev Labtech Venture Ltd

Preferential Issue of Convertible Warrants

Dev Labtech Venture Ltd has announced the outcome of its Board Meeting held on 7th October, 2026, where it considered and approved the increase in the authorized share capital of the company and the issuance of up to 1,37,00,000 convertible warrants to promoters and non-promoters on a preferential basis.

Read more →📎 1 attachment
BSECompany UpdateFundraise7 Oct 2026

Dev Labtech Venture Ltd

Increase in the Authorised Share Capital of the Company and amendment in Capital Clause of the Memorandum of Association: subject to the approval of shareholders at the ensuing Extra Ordinary General Meeting of the Company.

Dev Labtech Venture Ltd has increased its authorized share capital from Rs. 25 crore to Rs. 31 crore and amended its Memorandum of Association. The company also approved the issuance of up to 1.37 crore convertible warrants to promoters and non-promoters on a preferential basis.

Read more →📎 1 attachment
BSEBoard MeetingFundraise7 Oct 2026

Dev Labtech Venture Ltd

We hereby inform the Stock Exchange that the Board of Directors of the Company in their Meeting held on Wednesday, the 7th October, 2026 at the Office of the Company situated at Plot No. 53 - 54, 1st Floor, Thakordwar Society, Mini Bazar, Varachha Road, Surat - 395006, Gujarat, inter alia other businesses, has transacted the following main business: 1. Considered and approved the Increase in the Authorised Share Capital of the Company and amendment ....

Dev Labtech Venture Ltd has announced the outcome of its Board Meeting held on 7th October, 2026, where the Board approved the increase in the authorized share capital of the company and amendment in the capital clause of the Memorandum of Association, and also approved the issue of up to 1.37 crore convertible warrants to promoters and non-promoters on a preferential basis.

Read more →📎 1 attachment
BSEBoard MeetingFundraise3 Oct 2026

Dev Labtech Venture Ltd

Dev Labtech Venture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/10/2026 ,inter alia, to consider and approve 1. To increase authorized share capital of the Company. 2. To consider and evaluate proposals for raising of funds by way of issue of equity shares or any other eligible convertible securities, through preferential allotment, subject to all such regulatory/ statutory approvals as may ....

Dev Labtech Venture Ltd has scheduled a board meeting on 7th October 2026 to consider increasing authorized share capital and evaluating proposals for raising funds through preferential allotment.

Read more →📎 1 attachment
BSEInsider Trading / SAST26 Sept 2026

Dev Labtech Venture Ltd

Intimation of Closure of Trading Window of the Company.

Dev Labtech Venture Ltd has announced the closure of its trading window for insiders from 1st October 2026 till 48 hours after the declaration of unaudited financial results for the half year ended 30th September 2026.

Read more →📎 1 attachment
BSEAGM/EGM26 Sept 2026

Dev Labtech Venture Ltd

Proceedings of the 33rd Annual General Meeting held on 26th September, 2026.

Dev Labtech Venture Ltd held its 33rd Annual General Meeting (AGM) on September 26, 2026, through video conferencing. The meeting was attended by the Board Members, Key Managerial Personnel, and Auditors. The Chairperson delivered a speech on the company's performance and future prospects. The Statutory Auditors' Report and Secretarial Audit Report for FY 2025-26 did not contain any qualifications or adverse comments. The company provided e-voting facilities for its members to cast their votes electronically on all resolutions.

Read more →📎 1 attachment
BSEOthersResults1 Sept 2026

Dev Labtech Venture Ltd

Annual Report FY 2025-26

Dev Labtech Venture Ltd has filed its 33rd Annual Report for FY 2025-26, which includes the company's financial statements, directors' report, and other regulatory disclosures.

Read more →📎 1 attachment
Page 1 of 2Next →